• ქართული
  • English
  • Samsung BioLogics' listing under review after regulator says it breached accounting rules

    South Korea’s top financial regulator said Samsung BioLogics Co Ltd had intentionally breached accounting rules ahead of its 2016 listing, leading to a suspension in trading of the biotech firm’s shares and a review of its listing status.

    Market Quotes by TradingView